You have 9 free searches left this month | for more free features.

WHO grade II

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anesthesia, Local Trial in Minya (Intraligamental local anesthetic injection)

Completed
  • Anesthesia, Local
  • Intraligamental local anesthetic injection
  • Minya, Egypt
    Faculty of Dentistry, Minia University
May 26, 2023

Graft Vs Host Disease Trial in Vandoeuvre Les Nancy (Uvadex, Steroids)

Not yet recruiting
  • Graft Vs Host Disease
  • Vandoeuvre Les Nancy, France
    CHRU de Nancy
Nov 10, 2023

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Sep 20, 2022

Hamstring Injury Trial in Pittsburgh (Losartan, )

Recruiting
  • Hamstring Injury
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Dec 14, 2022

Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • +3 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Dec 21, 2022

Meningioma Trial in Chicago, Boston (AZD2014)

Active, not recruiting
  • Meningioma
  • Chicago, Illinois
  • +2 more
Oct 15, 2022

Cytomegalovirus Infections Trial (Cytotect®CP)

Recruiting
  • Cytomegalovirus Infections
  • Lille, France
    Hop Claude Huriez Chu Lille
Nov 8, 2022

Cholecystitis Trial in Izmir (Laparoscopic cholecystectomy)

Completed
  • Cholecystitis
  • Laparoscopic cholecystectomy
  • Izmir, Konak, Turkey
    University of Health Sciences Izmir Tepecik Training and Researc
Apr 23, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

WHO Grade II Glioma Trial in Japan (DS-1001b)

Active, not recruiting
  • WHO Grade II Glioma
  • Nagoya, Aichi, Japan
  • +10 more
Feb 3, 2022

Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)

Not yet recruiting
  • Vulvar Diseases
  • +12 more
  • Artesunate ointment
  • Placebo ointment
  • Cleveland, Ohio
  • +2 more
Oct 4, 2023

Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

Not yet recruiting
  • Low Grade Glioma
  • model-guided optimization of treatment plan
  • standard treatment plan, no optimization
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Jul 19, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Meningioma Atypical Trial in Milano (Radiosurgery)

Recruiting
  • Meningioma Atypical
  • Radiosurgery
  • Milano, Italy
    UOC Radioterapia
Oct 5, 2021

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +3 more
  • Clinical Observation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

Recruiting
  • Oligodendroglioma
  • +2 more
  • Radiation therapy
  • Oslo, Norway
    Oslo University Hospital
Jan 14, 2022

Endometrial Cancer Trial (Giredestrant)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Feb 1, 2023

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

Astrocytoma, Grade II, Astrocytoma, Grade III Trial in United States (TTFields with adjuvant temozolomide)

Terminated
  • Astrocytoma, Grade II
  • Astrocytoma, Grade III
  • TTFields with adjuvant temozolomide
  • Gainesville, Florida
  • +4 more
Aug 26, 2021

Furcation Defects, Periodontal Diseases Trial in Oslo (Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane

Recruiting
  • Furcation Defects
  • Periodontal Diseases
  • Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)
  • Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
  • Oslo, Norway
    Institute of Clinical Dentistry, Faculty of Dentistry, Universit
May 19, 2022

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Meningioma, Radiation Toxicity Trial in Caen, Rouen (Normo-fractionated intensity-modulated brain irradiation with or without

Recruiting
  • Meningioma
  • Radiation Toxicity
  • Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
  • +3 more
  • Caen, France
  • +1 more
Sep 13, 2023

CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic

Recruiting
  • CIN3
  • +3 more
  • Vvax001 therapeutic cancer vaccine
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

Active, not recruiting
  • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • External Beam Radiation Therapy
  • Orbital Radiation
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022